Press Releases Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Real-time Estimate Cboe BZX Other stock markets 01:07:49 2024-05-17 pm EDT			5-day change	1st Jan Change
0.283 ^USD	+3.36%		+14.94%	-50.08%

May. 07	Top Midday Gainers	MT
May. 07	Nuwellis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida	May. 14	AQ
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy	May. 09	AQ
Nuwellis, Inc. Announces First Quarter 2024 Financial Results	May. 07	AQ
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology	May. 02	AQ
Nuwellis Announces Closing of $2.7 Million Public Offering	Apr. 30	AQ
Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024	Apr. 30	AQ
Nuwellis Announces Pricing of $2.7 Million Public Offering	Apr. 26	AQ
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health	Apr. 09	AQ
Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference	Mar. 07	AQ
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 05	AQ
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024	Feb. 27	AQ
Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™	Feb. 22	AQ
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Feb. 20	AQ
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference	Feb. 20	AQ
New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload	Feb. 06	AQ
Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter	Jan. 04	AQ
New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients	Nov. 28	AQ
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Nov. 14	AQ
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results	Nov. 07	AQ
Nuwellis Announces Board of Directors Transition	Nov. 01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nuwellis, Inc.

Equities

NUWE

US67113Y4052

Press Releases

Filters